Sentry Data Systems has achieved the top ranking in the annual 340B Pharmacy Management Systems Black Book Research report, including the highest scores for user experience and outcomes.
Lisa Scholz has been nominated as a candidate for a board position with the American Pharmacists Association Academy of Pharmacy Practice & Management (APhA-APPM).
Attending the ASHP Midyear 2020 Clinical Meeting? We’d love to “see” you at our first Sentry symposium December 7 – 10! We’ll be conducting a mix of large group webinars and smaller roundtable sessions with key Sentry executives. Space is limited so sign up today!
Sentry Data Systems and its stand-alone sister company, Agilum, have partnered with Actifio, the pioneer of copy data management, to provide near-immediate virtual database access to use existing data for in-depth analytics. Working…
Reductions in federal funding or 340B drug benefits to clinics would have a devastating effect on efforts to manage the public health crisis.
340B is now under attack with a strategy designed to reduce benefit to both patients and covered entities. Lisa Scholz’s presentation provides insights into how executive teams can prepare, respond and influence to protect the hospitals and communities they serve in the face of such challenges.
Modern Healthcare spoke with Lisa Scholz, PharmD, FACHE, Sentry’s Head of Industry Relations, for a recent article, “Drugmakers crackdown on 340B discounts, demand data.”
Sentry Data Systems, Inc., the nation’s leader in pharmacy procurement, compliance and utilization management, announced today the release of its Referral Verification System™ (RVS™), to help 340B safety net providers improve the continuity of patient care by automating patient referral relationships.